Search
03/05/2023
The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients' Life-The Spanish Patients' Perspective
Dominguez-Ortega J., Plaza V., Nieto A., Romero J.D., Ancochea J., Mejia N., Pastor M., Blanco-Aparicio M.. The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients' Life-The Spanish Patients' Perspective. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S404525. PMID:37163179. IF:3.700(Q1/3D).
17/04/2023
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors
Menendez, R, Mendez, R, Latorre, A, Gonzalez-Jimenez, P, Peces-Barba, G, Molina, M, Espana, PP, Garcia, E, Consuegra-Vanegas, A, Pando-Sandoval, A, Panadero, C, Figueira-Goncalves, JM, de la Rosa, D, Sibila, O, Martinez-Pitarch, MD, Toledo, N, Cejudo, P, Almonte-Batista, W, Macias-Paredes, A, Badenes, D, Perez-Rodas, EN, Lazaro, J, Quiros, S, Cordovilla, R, Cano-Pumarega, I, Torres, A. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors. JOURNAL OF INTERNAL MEDICINE. 2023; 294(1)DOI:10.1111/joim.13642. PMID:37038609. IF:9.000(Q1/1D).
03/04/2023
The role of precision medicine in bronchiectasis: emerging data and clinical implications
Oscullo G., de la Rosa D., Clemente, MG, Giron R., Golpe R., Máiz L., Martinez-Garcia M.A.. The role of precision medicine in bronchiectasis: emerging data and clinical implications. Expert Review of Respiratory Medicine. 2023; 17(4)DOI:10.1080/17476348.2023.2205125. PMID:37077039. IF:2.900(Q2/4D).
01/04/2023
The immunoregulatory role of IL-35 in patients with interstitial lung disease
Osuna-Gomez, R, Barril, S, Mulet, M, Atenza, CZ, Millan-Billi, P, Pardessus, A, Brough, DE, Sabzevari, H, Semnani, RT, Castillo, D, Vidal, S. The immunoregulatory role of IL-35 in patients with interstitial lung disease. IMMUNOLOGY. 2023; 168(4)DOI:10.1111/imm.13596. PMID:36273280. IF:4.900(Q2/3D).